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THE THORACIC SURGERY FOUNDATION FOR RESEARCH AND EDUCATION
Program Announcement for The Thoracic Surgery Foundation for Research and Education and the National
Heart, Lung, and Blood Institute: Jointly Sponsored Mentored Clinical Scientist Development Award (K08)
Eligibility requirements
The candidate must have an MD degree or its equiva-
lent, must have initiated postgraduate clinical training in
thoracic surgery, must identify a mentor with extensive
research experience, and must be willing to spend a min-
imum of 75 percent of full-time professional effort con-
ducting research and research career development.
Applications may be submitted, on behalf of candi-
dates, by domestic, non-Federal organizations, public or
private, such as medical, dental, or nursing schools or
other institutions of higher education. Minorities and
women are encouraged to apply. Candidates must be US
citizens or noncitizen nationals, or must have been law-
fully admitted for permanent residence and possess an
Alien Registration Receipt Card (I-151 or I-551) or some
other verification of legal admission as a permanent resi-
dent. Noncitizen nationals, though not US citizens, owe
permanent allegiance to the United States. They are usu-
ally born in lands that are not states but are under US sov-
ereignty, jurisdiction, or administration. Individuals on
temporary or student visas are not eligible.
Former principal investigators of National Institutes of
Health research project grants (R01), FIRST Awards
(R29), sub-projects of program projects (P01) or center
grants (P50), or the equivalent, are not eligible. A candi-
date for the MCSDA may not concurrently apply for any
other Public Health Service (PHS) award that duplicates
the provisions of this award nor have another application
pending award. MCSDA recipients are encouraged to
apply for independent research grant support during the
period of this award. Questions regarding eligibility
requirements should be directed to the NHLBI contact
listed at the end of this announcement.
Mechanism of support 
Awards in response to this program announcement
will use the K08 mechanism. Planning, direction, and
execution of the program will be the responsibility of
the candidate and his or her mentor on behalf of the
applicant institution. The project period will be 5 years.
Awards are not renewable.
The Thoracic Surgery Foundation for Research andEducation (TSFRE), through grants from The
William J. von Liebig Foundation and Datascope Corp,
and the National Heart, Lung, and Blood Institute
(NHLBI) wish to announce a program of jointly spon-
sored Mentored Clinical Scientist Development
Awards (K08), directed at thoracic surgeons in the
early stages of their research careers.
Purpose
The purpose of the Mentored Clinical Scientist
Development Award (MCSDA) is to support the devel-
opment of outstanding clinician research scientists.
This mechanism provides specialized study for clini-
cally trained professionals who are committed to a
career in research and have the potential to develop into
independent investigators. The award supports a 5-year
period of supervised research experience that integrates
didactic studies with laboratory or clinically based
research. The proposed research should have both
intrinsic research importance and be a vehicle for
learning the methodology, theories, and conceptualiza-
tions necessary for a well-trained independent
researcher.
Because of the focus on progression to indepen-
dence, the prospective candidate should propose a
period of study and development consistent with this
goal and his or her previous research and clinical
experience. For example, a candidate with limited
experience in a given field of research may find a
phased developmental program lasting for 5 years,
which includes a designated period of didactic train-
ing and supervised research experience, the most
efficient means of attaining independence. A candi-
date with substantial previous research experience
may require a shorter period for class work and
supervised training and more time for laboratory
work appropriate for the transition to independence.
The entire program should be comparable in scope
and rigor to meeting the requirements of an advanced
research degree.
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Research objectives
A. Environment. The institution must have a well-
established research and clinical career development
program and a qualified faculty in clinical and basic
research to serve as mentors. The institution must be
able to demonstrate a commitment to the development
of the candidate as a productive, independent investiga-
tor. And, the candidate, mentor, and institution must be
able to describe a multi-disciplinary career develop-
ment program that will maximize the use of relevant
research and educational resources. 
B. Program. The Award provides 5 consecutive 12-
month appointments. At least 75 percent of the recipi-
ent’s full-time professional effort must be devoted to
the program and the remainder devoted to other clinical
and teaching pursuits consonant with the objectives of
the award. The basic science component must develop
knowledge and research skills in scientific areas rele-
vant to the career goals of the candidate.
C. Mentor(s). The recipient must receive appropriate
mentoring throughout the 5-year program. Where fea-
sible, women and minority mentors should be involved
as role models.
D. Allowable costs. Each of the sponsoring organi-
zations (TSFRE and NHLBI) will award salary up to
$75,000 per year. In the application to the NIH, the
applicant may also request funds for research develop-
ment support up to $ 25,000. The applicant must sub-
mit a categorical budget; modular budgets will not be
accepted. Annual escalation, if any, will be determined
by the current NHLBI policy.
1. Salary support. TSFRE and the NHLBI will each
provide salary. It is anticipated that up to $150,000 a
year will be used for salary for the award recipient, plus
fringe benefits.
The institution may supplement the contribution of
TSFRE and NHLBI up to a level that is consistent with
the institution’s salary scale; however, supplementation
may not be from Federal funds unless specifically
authorized by the Federal program from which such
funds are derived. In no case may PHS funds be used
for salary supplementation. Institutional supplementa-
tion of salary must not require extra duties or responsi-
bilities that would interfere with the purpose of the
MCSDA.
2. Research development support. It is anticipated
that up to $25,000 per year of the NHLBI award will be
used by the recipient for research-related expenses,
including (a) tuition, fees, and books related to career
development; (b) research expenses, such as supplies,
equipment, and technical personnel; (c) travel to
research meetings or training; and (d) statistical ser-
vices including personnel and computer time.
3. Facilities and administrative (F&A) costs. F&A
costs will be reimbursed at 8 percent of the allowable
direct costs contributed by the NHLBI. TSFRE will not
reimburse F&A costs.
Application procedures
Applications should conform to the guidelines pub-
lished in the document “Mentored Clinical Scientist
Development Award” dated October 8, 1999, and the
document “NHLBI Supplemental Information to the
NIH Mentored Clinical Scientist Development Award”
dated November 18, 1999.
Applicants should note the NHLBI recommends, but
does not require, the establishment of an Advisory
Committee composed of the candidate’s mentor and at
least two other senior faculty members to review the
candidate’s progress on an annual basis.
Applications are to be submitted on form PHS 398
(rev. 4/98) and will be accepted on or before the receipt
deadline of June 1, 2001. Forms are available at most
institutional offices of sponsored research and from the
Office of Grants Information, Center for Scientific
Review, NIH, 6701 Rockledge Drive, MSC 7710,
Bethesda, MD 20892, telephone 301-435-0714. Copies
of the form may also be printed from the NIH Web site
at the following address:
http://www.nih.gov/grants/funding/phs398/phs39
8.html
Please take note that the maximum salary budget to
be requested of the NHLBI using Form PHS 398 is
$75,000. Any request over $75,000 in salary support
may be cause for rejection of the application by the
Center for Scientific Review of the NIH. As a function
of the overall awards program and separate and distinct
from the NHLBI application, TSFRE will be contribut-
ing $75,000 in addition to the amount awarded by the
NHLBI under the K08 provisions.
To identify the application as a response to this pro-
gram announcement, check “YES” on item 2 of page 1
of the application and enter “PA-00-003, Mentored
Clinical Scientist Development Award: Assign to
NHLBI.” Submit a signed, typewritten original of the
application with Checklist and five signed photocopies,
in one package to: Center for Scientific Review,
National Institutes of Health, 6701 Rockledge Drive,
Room 1040, MSC 7710, Bethesda, MD 20892-7710
(20817-7710 for express/courier service) and five
signed photocopies to the Research Committee of
TSFRE. In addition, send one photocopy to Dr Sonia
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Skarlatos, Director, Vascular Biology Research
Program, Division of Heart and Vascular Diseases,
NHLBI, Two Rockledge Centre, Suite 10198, MSC
7956, Bethesda, MD 20892-7956.
Review consideration
Applications will be reviewed for completeness by
the Center for Scientific Review and for responsive to
this program announcement by TSFRE and by NHLBI.
Applications that are complete and responsive to the
program announcement will be evaluated for scientific
and technical merit by an appropriate peer review
group convened at the NHLBI in accordance to the
standard NIH peer review procedures. TSFRE will par-
ticipate in the NIH peer review group. As part of the
initial merit review, all applications will receive a writ-
ten critique and undergo a process in which only those
applications deemed to have highest scientific merit,
generally the top half of the applications under review,
will be discussed, assigned a priority score, and receive
a second-level review by the National Heart, Lung, and
Blood Advisory Council. The application will also
receive a secondary review by TSFRE.
Award process
TSFRE and the NHLBI will notify the applicants of
the joint action of TSFRE and the NHLBI Council
shortly after the Council meeting in February. It is
anticipated that up to two jointly sponsored MCSDA
awards will be made each year and the name(s) of the
awardee(s) will be announced by TSFRE.
Contacts
For questions regarding eligibility requirements and
the K08 application process:
Ms Beth Schucker, MA
Leader of Research Training and Special Programs
Division of Heart and Vascular Diseases
National Institutes of Health
6701 Rockledge Drive
Suite 9140, MSC 7710
Bethesda, MD 20892-7956
Telephone: 301-435-0553
For questions regarding TSFRE:
Frank J. Kurtz, PhD
Executive Director
The Thoracic Surgery Foundation for Research and
Education
401 North Michigan Avenue
Suite 2200
Chicago, IL 60611-4267
Telephone: 312-644-6610, ext 3425
Fax: 312-527-6635
